Catalent Inc (CTLT)

Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Apr 23, 2025

Silexion Partners With Catalent To Advance SIL204 SiRNA Therapy For KRAS-Driven Cancers - Nasdaq

Apr 23, 2025

Apr 23, 2025

Silexion Therapeutics Enters Strategic Collaboration with Catalent to Advance SIL204 Development for KRAS-Driven Cancers - Nasdaq

Apr 23, 2025

Apr 23, 2025

Major Breakthrough: Silexion's Multi-KRAS Cancer Drug Enters Manufacturing Phase with Industry Giant Catalent - Stock Titan

Apr 23, 2025

Apr 20, 2025

Lisata Therapeutics talks ADC breakthrough with Catalent – ICYMI - Proactive financial news

Apr 20, 2025

Apr 17, 2025

Lisata Therapeutics announces research license with Catalent - MSN

Apr 17, 2025

Apr 16, 2025

Lisata Therapeutics CMO discusses potential for certepetide under Catalent license agreement - Proactive financial news

Apr 16, 2025

Apr 16, 2025

Lisata, Catalent partner for cancer drug research - Investing.com

Apr 16, 2025

Apr 15, 2025

Lisata, Catalent partner for cancer drug research By Investing.com - Investing.com South Africa

Apr 15, 2025

Apr 15, 2025

Lisata Therapeutics (LSTA) Partners with Catalent on Preclinical Study | LSTA Stock News - GuruFocus

Apr 15, 2025

Apr 15, 2025

Lisata Therapeutics Announces Research License with Catalent - GlobeNewswire

Apr 15, 2025

Apr 15, 2025

Lisata Therapeutics, Inc. Announces Research License with Catalent, Inc - marketscreener.com

Apr 15, 2025

Apr 13, 2025

Catalent Announces the Appointment of David Schaffer to Biologics Advisory Board - marketscreener.com

Apr 13, 2025

Apr 07, 2025

Catalent's Journey Of Continuous Improvement For CSV Excellence - Bioprocess Online

Apr 07, 2025

Apr 07, 2025

Trump’s Tariff Threat Sparks Race to Find US Drug Manufacturers - Yahoo Finance

Apr 07, 2025

Mar 18, 2025

Jupiter Neurosciences, Catalent Partner to Produce JOTROL Softgels for Upcoming Trial - Contract Pharma

Mar 18, 2025

Mar 13, 2025

CRDMO Market Research 2025: A Highly Competitive $328 Billion Market by 2029 with Lonza Group, WuXi, Catalent, Sai Life Sciences, Syngene, Jubilant Biosys, and Thermo Fisher Scientific Leading - Yahoo Finance

Mar 13, 2025

Mar 07, 2025

Unit Dose Manufacturing Industry Report 2025-2030: Market to Cross $150.6 Billion Led by Catalent, Unither Pharmaceuticals, and Thermo Fisher Scientific - Yahoo Finance

Mar 07, 2025

Mar 05, 2025

Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight - GlobeNewswire

Mar 05, 2025

Mar 03, 2025

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Catalent, Inc. (CTLT) Investigation - ACCESS Newswire

Mar 03, 2025

Feb 28, 2025

Healthcare CMO Market Projected To Witness Substantial Growth, 2025-2032: Lonza Group, Catalent, Inc., Aenova - EIN News

Feb 28, 2025

Feb 27, 2025

Per-Encounter Medical Market to Witness Remarkable Growth with Catalent Inc., Smiths Medical Inc., Cardinal Health - openPR

Feb 27, 2025

Feb 21, 2025

Catalent announces new board appointments - ROI-NJ

Feb 21, 2025

Feb 20, 2025

Catalent Appoints Susan Mahony, Marie-France Tschudin and Tim Walbert to its Board of Directors - citybiz

Feb 20, 2025

Feb 20, 2025

Catalent Announces New Board Appointments - Business Wire

Feb 20, 2025

Feb 10, 2025

Novo to grow Catalent? Rumor mill spins amid Trump tariff threat - BioProcess Insider

Feb 10, 2025

Feb 07, 2025

Jupiter Neurosciences partners with Catalent for Parkinson's trial - MSN

Feb 07, 2025

Feb 04, 2025

Ardena Acquires Catalent’s Drug Product Manufacturing Facility in Somerset, NJ - Contract Pharma

Feb 04, 2025

Feb 04, 2025

Ardena Completes Acquisition of Advanced Drug Product Manufacturing Facility from Catalent and Expands Bioanalytical Services in North America - Yahoo Finance

Feb 04, 2025

Feb 03, 2025

Jupiter Neurosciences Partners With Catalent For Parkinson's JOTROL Trial Production - Nasdaq

Feb 03, 2025

Feb 03, 2025

Jupiter Neurosciences Signs Manufacturing Deal With Catalent Pharma for Jotrol Softgel Capsules - Marketscreener.com

Feb 03, 2025

Feb 03, 2025

Jupiter Neurosciences Partners with Catalent to Produce JOTROL Softgels for Upcoming Clinical Trial - Contract Pharma

Feb 03, 2025

Feb 03, 2025

Jupiter Neurosciences partners with Catalent for Parkinson's trial By Investing.com - Investing.com South Africa

Feb 03, 2025

Feb 03, 2025

Jupiter Neurosciences Announces JOTROL Manufacturing Agreement with Catalent to Support Phase 2a Parkinson's Trial - The Manila Times

Feb 03, 2025

Feb 03, 2025

Jupiter Neurosciences Announces JOTROL Manufacturing - GlobeNewswire

Feb 03, 2025

Feb 03, 2025

Major Breakthrough: New Parkinson's Drug Manufacturing Deal Could Fast-Track Treatment for 10M Patients - StockTitan

Feb 03, 2025

Feb 03, 2025

How Novo’s Acquisition Of Catalent Cleared European Regulators - Citeline

Feb 03, 2025

Jan 28, 2025

Catalent (CTLT) to Report Q2 Earnings: What's in the Cards? - MSN

Jan 28, 2025

Jan 28, 2025

Catalent (NYSE:CTLT) Now Covered by StockNews.com - Defense World

Jan 28, 2025

Jan 26, 2025

Pace Life Sciences Expands Capacity and Capability With Acquisition of Catalent’s Analytical Services Laboratory in Research Triangle Park - ACCESS Newswire

Jan 26, 2025

Jan 23, 2025

Catalent's Award-Winning Innovations and Community Engagement Initiatives - Pharmaceutical Technology

Jan 23, 2025

Jan 23, 2025

Catalent to make CAR-T for Galapagos; Kindeva gets $129M for nerve agent antidote - Endpoints News

Jan 23, 2025

Jan 22, 2025

Catalent backs decentralised manufacture of Galapagos’ CAR-T therapy - MSN

Jan 22, 2025

Jan 22, 2025

Catalent to further expand Galapagos’ decentralized CAR-T manufacturing network in US - Indian Pharma Post

Jan 22, 2025

Jan 21, 2025

Catalent to support Galapagos’ decentralized cell therapy approach - The Pharma Letter

Jan 21, 2025

Jan 21, 2025

Catalent to Support Galapagos’ Decentralized CAR-T Therapy Trials - Contract Pharma

Jan 21, 2025